Access Statistics for Anirban Basu

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Choosing Wisely: Evaluating Latent Factor Models in the Presence of a Contaminated Instrumental Variable with Varying Strength 1 1 1 1 3 24 24 24
Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures 0 1 1 47 1 4 5 85
Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California 1 2 2 12 1 3 6 17
Dynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies 0 0 1 5 1 1 5 15
Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care 0 0 0 47 0 0 0 174
Estimating Lifetime or Episode-of-illness Costs 0 0 0 108 0 0 2 285
Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables 0 0 0 52 0 0 1 154
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 18 0 1 1 98
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 39 0 3 8 190
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 2 46 1 1 4 161
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 0 290 0 0 1 872
Hidden Figures: Uncovering Quantities Behind Zeros with Econometrics 0 0 1 16 0 0 2 21
Impact of Rural and Urban Hospital Closures on Inpatient Mortality 0 0 1 86 0 2 7 156
Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State 0 0 0 16 0 0 0 37
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting 0 0 0 62 0 1 2 94
Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion 0 0 0 50 0 0 0 34
Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment 0 0 0 7 0 0 1 50
The Impact of Comparative Effectiveness Research on Health and Health Care Spending 0 0 0 57 1 1 1 229
The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices 0 0 0 73 0 0 2 102
The Role of Physician Altruism in the Physician-Industry Relationship: Evidence from Linking Experimental and Observational Data 0 2 10 10 0 3 15 15
The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health 0 0 0 42 0 0 1 101
The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures 0 0 0 42 0 0 4 162
Understanding Algorithmic Discrimination in Health Economics Through the Lens of Measurement Errors 0 0 0 21 0 0 1 50
Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures 0 0 1 54 0 0 2 218
Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients 0 0 2 483 0 1 7 1,342
Use of propensity scores in non-linear response models: The case for health care expenditures 0 0 0 146 0 0 6 520
Welfare Implications of Learning Through Solicitation versus Diversification in Health Care 0 0 0 36 0 0 0 55
Total Working Papers 2 6 22 1,866 8 45 108 5,261


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS? 0 0 0 3 0 0 0 24
Comparing alternative models: log vs Cox proportional hazard? 0 1 2 148 1 2 4 571
Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients? 0 0 0 0 0 0 2 315
ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS 0 0 0 6 0 1 3 42
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care 0 0 0 29 0 1 4 245
Erratum: Estimating lifetime or episode‐of‐illness costs under censoring 0 0 0 15 0 0 0 46
Estimating lifetime or episode‐of‐illness costs under censoring 0 0 1 21 0 0 3 81
Extended generalized linear models: Simultaneous estimation of flexible link and variance functions 0 1 1 145 0 1 4 420
Generalized modeling approaches to risk adjustment of skewed outcomes data 0 0 1 143 0 0 2 358
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 0 0 0 24
HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE 0 1 3 105 0 1 6 288
Implications of spillover effects within the family for medical cost-effectiveness analysis 0 0 0 72 1 1 1 185
Measuring the Value of Pharmaceuticals in the US Health System 0 0 0 5 0 0 0 14
Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables 0 1 2 39 0 3 11 152
Personalized Medicine in the Context of Comparative Effectiveness Research 0 0 0 13 0 0 1 102
Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials 0 0 0 5 0 0 0 47
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 0 1 0 0 1 18
Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity 0 0 0 52 0 0 0 217
The impact of comparative effectiveness research on health and health care spending 0 0 0 35 0 1 2 275
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling 0 1 6 923 2 5 23 2,705
Welfare implications of learning through solicitation versus diversification in health care 0 0 0 2 0 0 0 34
Total Journal Articles 0 5 16 1,764 4 16 67 6,163


Software Item File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
IVCHECK: Stata module to choose between OLS and contaminated IV 1 3 4 28 2 6 19 240
Total Software Items 1 3 4 28 2 6 19 240


Statistics updated 2025-07-04